1887

Abstract

Congenital sensorineural hearing loss (SNHL) is common. In theWestern world, the incidence is 1–3 per 1000 live births. The aetiologyencompasses genetic and non-genetic factors accounting for 55 %and 45 % of cases, respectively. Reports that describe the contributionof intrauterine infection to the occurrence of congenital SNHL are limited,and comparative analysis of the different pathogens is lacking. Lipopolysaccharide (LPS),a product of bacteriolysis, has been demonstrated to be associated with innerear damage in experimental studies. To elucidate the potential role of thistoxin in congenital SNHL and to identify the pathogenesis and transmissionroutes, we reviewed the literature. We speculate that different routes ofexposure to LPS may result in congenital inner ear damage.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.015792-0
2010-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/4/377.html?itemId=/content/journal/jmm/10.1099/jmm.0.015792-0&mimeType=html&fmt=ahah

References

  1. Abramovich S. J., Gregory S., Slemick M., Stewart A. 1979; Hearing loss in very low birthweight infantstreated with neonatal intensive care. Arch Dis Child 54:421–426 [CrossRef]
    [Google Scholar]
  2. Amaee F. R., Comis S. D., Osborne M. P., Drew S., Tarlow M. J. 1997; Possible involvement of nitric oxidein the sensorineural hearing loss of bacterial meningitis. ActaOtolaryngol 117:329–336
    [Google Scholar]
  3. Bernstein J. M., Praino M. D., Neter E. 1980; Detection of endotoxin in ear specimens from patients withchronic otitis media by means of the limulus amebocyte lysate test. Can J Microbiol 26:546–548 [CrossRef]
    [Google Scholar]
  4. Cock M. L., Dalitz P. A., Harding R. 2002; Reduced placental perfusion following endotoxin administrationto the preterm ovine fetus. Pediatr Res 51:450
    [Google Scholar]
  5. Comis S. D., Osborne M. P., Tarlow M. J. 1991; The effect of bacterial endotoxin upon the morphology ofthe tectorial membrane and stereocilia in the guinea pig cochlea. Scanning Microsc 5:1129–1133
    [Google Scholar]
  6. Cureoglu S., Schachern P. A., Rinaldo A., Tsuprun V., Ferlito A., Paparella M. M. 2005; Round window membraneand labyrinthine pathological changes: an overview. Acta Otolaryngol 125:9–15 [CrossRef]
    [Google Scholar]
  7. Darrow D. H., Keithley E. M., Harris J. P. 1992; Effects of bacterial endotoxin applied to the guinea pigcochlea. Laryngoscope 102:683–688 [CrossRef]
    [Google Scholar]
  8. Davis A., Wood S., Healy R., Webb H., Rowe S. 1995; Risk factors for hearing disorders: epidemiologicevidence of change over time in the UK. J Am Acad Audiol 6:365–370
    [Google Scholar]
  9. DeMaria T. F., Prior R. B., Briggs B. R., Lim D. J., Birck H. G. 1984; Endotoxin in middle-ear effusionfrom patients with chronic otitis media with effusion. J Clin Microbiol 20:15–17
    [Google Scholar]
  10. Engel F., Blatz R, Kellner J, Palmer M, Weller U, Bhadki S. 1995; Breakdown of the round window membranepermeability barrier evoked by streptolysin O: possible etiologic role indevelopment of sensorineural hearing loss in acute otitis media. Infect Immun 63:1305–1310
    [Google Scholar]
  11. Erenberg A., Lemons J., Sia C., Trunkel D., Ziring P. 1999; Newborn and infant hearing loss: detectionand intervention. American Academy of Pediatrics. Task Force on Newborn andInfant Hearing 1998-1999 Pediatrics 103:527–530 [CrossRef]
    [Google Scholar]
  12. Fessenden J. D., Schacht J. 1998; The nitric oxide/cyclic GMP pathway: a potential major regulatorof cochlear physiology. Hear Res 118:168–176 [CrossRef]
    [Google Scholar]
  13. Forstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I., Kleinert H. 1994; Nitric oxidesynthase isozymes. Characterization, purification, molecular cloning, andfunctions. Hypertension 23:1121–1131 [CrossRef]
    [Google Scholar]
  14. Garcia Berrocal J. R., Ramirez-Camacho R. 2000; Immune response and immunopathology of the inner ear: anupdate. J Laryngol Otol 114:101–107
    [Google Scholar]
  15. Goldberg B., Goycoolea M. V., Schleivert P. M., Shea D., Schachern P., Paparella M. M., Carpenter A. M. 1981; Passage of albumin from the middle ear to the inner ear in otitismedia in the chinchilla. Am J Otolaryngol 2:210–214 [CrossRef]
    [Google Scholar]
  16. Goldenberg R. L., Hauth J. C., Andrews W. W. 2000; Intrauterine infection and preterm delivery. N Engl J Med 342:1500–1507 [CrossRef]
    [Google Scholar]
  17. Goycoolea M. V. 2001; Clinical aspectsof round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 121:437–447 [CrossRef]
    [Google Scholar]
  18. Goycoolea M. V., Paparella M. M., Juhn S. K., Carpenter A. M. 1980; Oval and round window changes in otitismedia. Potential pathways between middle and inner ear. Laryngoscope 90:1387–1391
    [Google Scholar]
  19. Goycoolea M. V., Muchow D., Schachern P. 1988; Experimental studies on round window structure: functionand permeability. Laryngoscope 98:1–20
    [Google Scholar]
  20. Gross M., Finckh-Kramer U., Spormann-Lagodzinski M. 2000; Congenital hearing disorders in children.1: Acquired hearing disorders. HNO 48:879–886 [CrossRef]
    [Google Scholar]
  21. Guo Y., Wu Y., Chen W., Lin J. 1994; Endotoxic damage to the stria vascularis: the pathogenesis of sensorineuralhearing loss secondary to otitis media?. J Laryngol Otol 108:310–313
    [Google Scholar]
  22. Guzik T. J., Korbut R., Adamek-Guzik T. 2003; Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469–487
    [Google Scholar]
  23. Harris J. P., Heydt J., Keithley E. M., Chen M. C. 1997; Immunopathology of the inner ear: an update. Ann N Y Acad Sci 830:166–178 [CrossRef]
    [Google Scholar]
  24. Hess A., Bloch W., Arnhold S., Andressen C., Stennert E., Addicks K., Michel O. 1998; Nitric oxidesynthase in the vestibulocochlear system of mice. Brain Res 813:97–102 [CrossRef]
    [Google Scholar]
  25. Hess A., Bloch W., Huverstuhl J., Su J., Stennert E., Addicks K., Michel O. 1999; Expression of induciblenitric oxide synthase (iNOS/NOS II) in the cochlea of guineapigs after intratympanical endotoxin-treatment. Brain Res 830:113–122 [CrossRef]
    [Google Scholar]
  26. Iadecola C., Xu X., Zhang F., el-Fakahany E. E., Ross M. E. 1995a; Marked induction of calcium-independentnitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab 15:52–59 [CrossRef]
    [Google Scholar]
  27. Iadecola C., Zhang F., Xu S., Casey R., Ross M. E. 1995b; Inducible nitric oxide synthase gene expressionin brain following cerebral ischemia. J Cereb Blood Flow Metab 15:378–384 [CrossRef]
    [Google Scholar]
  28. Iino Y., Kaneko Y., Takasaka T. 1985; Endotoxin in middle ear effusions tested with Limulus assay. Acta Otolaryngol 100:42–50 [CrossRef]
    [Google Scholar]
  29. Jobe A. H., Newnham J. P., Willet K. E., Sly P., Ervin M. G., Bachurski C., Possmayer F., Hallman M., Ikegami M. 2000; Effects of antenatal endotoxin and glucocorticoidson the lungs of preterm lambs. Am J Obstet Gynecol 182:401–408 [CrossRef]
    [Google Scholar]
  30. Juhn S. K., Hamaguchi Y., Goycoolea M. 1989; Review of round window membrane permeability. Acta Otolaryngol Suppl 457:43–48
    [Google Scholar]
  31. Jung T. T., Llaurado R. J., Nam B. H., Park S. K., Kim P. D., John E. O. 2003; Effects of nitricoxide on morphology of isolated cochlear outer hair cells: possible involvementin sensorineural hearing loss. Otol Neurotol 24:682–685 [CrossRef]
    [Google Scholar]
  32. Kallapur S. G., Jobe A. H., Ball M. K., Nitsos I., Moss T. J., Hillman N. H., Newnham J. P., Kramer B. W. 2007; Pulmonary and systemic endotoxin tolerance in preterm fetalsheep exposed to chorioamnionitis. J Immunol 179:8491–8499 [CrossRef]
    [Google Scholar]
  33. Kastenbauer S., Klein M., Koedel U., Pfister H. W. 2001; Reactive nitrogen species contribute to blood-labyrinthbarrier disruption in suppurative labyrinthitis complicating experimentalpneumococcal meningitis in the rat. Brain Res 904:208–217 [CrossRef]
    [Google Scholar]
  34. Katano H., Sato Y., Tsutsui Y., Sata T., Maeda A., Nozawa N., Inoue N., Nomura Y., Kurata T. 2007).Pathogenesis; of cytomegalovirus-associated labyrinthitis in a guinea pig model. Microbes Infect 9:183–191 [CrossRef]
    [Google Scholar]
  35. Kawauchi H., DeMaria T. F., Lim D. J. 1989; Endotoxin permeability through the round window. Acta Otolaryngol Suppl 457:100–115
    [Google Scholar]
  36. Kim C. S., Kim H. J. 1995).Auditory; brain stem response changes after application of endotoxin to theround window membrane in experimental otitis media. OtolaryngolHead Neck Surg 112:557–565
    [Google Scholar]
  37. Klein M., Koedel U., Kastenbauer S., Pfister H. W. 2008; Nitrogen and oxygen molecules in meningitis-associatedlabyrinthitis and hearing impairment. Infection 36:2–14 [CrossRef]
    [Google Scholar]
  38. Kramer B. W. 2008; Antenatal inflammationand lung injury: prenatal origin of neonatal disease. J Perinatol 28:S21–S27 [CrossRef]
    [Google Scholar]
  39. Kramer B. W., Ikegami M., Moss T. J., Nitsos I., Newnham J. P., Jobe A. H. 2005a; Endotoxin-inducedchorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am J Respir Crit Care Med 171:73–77 [CrossRef]
    [Google Scholar]
  40. Kramer B. W., Kaemmerer U., Kapp M., Herbst D., Marx A., Berg D., Groneck P. A., Speer C. P. (2005b).Decreased expression of angiogenic factors in placentas with chorioamnionitisafter preterm birth. Pediatr Res 58:607–612 [CrossRef]
    [Google Scholar]
  41. Kramer B. W., Joshi S. N., Moss T. J., Newnham J. P., Sindelar R., Jobe A. H., Kallapur S. G. 2007; Endotoxin-inducedmaturation of monocytes in preterm fetal sheep lung. Am J PhysiolLung Cell Mol Physiol 293:L345–L353
    [Google Scholar]
  42. Kramer B. W., Kallapur S., Newnham J., Jobe A. H. 2009a; Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14:2–7 [CrossRef]
    [Google Scholar]
  43. Kramer B. W., Ladenburger A., Kunzmann S., Speer C. P., Been J. V., van Iwaarden J. F., Zimmermann L. J., Gantert M., Garnier Y. 2009b; Intravenous lipopolysaccharide-inducedpulmonary maturation and structural changes in fetal sheep. AmJ Obstet Gynecol 200: 195.e1–195.e10
    [Google Scholar]
  44. Lee S. E., Romero R, Jung H, Park C. W., Park J. S., Yoon B. H. 2007; The intensity of the fetal inflammatoryresponse in intraamniotic inflammation with and without microbial invasionof the amniotic cavity. Am J Obstet Gynecol 197: 294.e1–294.e6 [CrossRef]
    [Google Scholar]
  45. Li L., Kosugi I., Han G. P., Kawasaki H., Arai Y., Takeshita T., Tsutsui Y. 2008; Induction of cytomegalovirus-infectedlabyrinthitis in newborn mice by lipopolysaccharide: a model for hearing lossin congenital CMV infection. Lab Invest 88:722–730 [CrossRef]
    [Google Scholar]
  46. Liaudet L., Soriano F. G., Szabo C. 2000; Biology of nitric oxide signaling. Crit Care Med 28:N37–N52 [CrossRef]
    [Google Scholar]
  47. Lim D. J., Kawauchi H., DeMaria T. F. 1990; Role of middle ear endotoxin in inner ear inflammatory responseand hydrops: long-term study. Ann Otol Rhinol Laryngol Suppl 148:33–34
    [Google Scholar]
  48. Ludwig A., Hengel H. 2009).Epidemiological; impact and disease burden of congenital cytomegalovirus infectionin Europe. Euro Surveill 14:26–32
    [Google Scholar]
  49. Marlow E. S., Hunt L. P., Marlow N. 2000; Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed 82:F141–F144
    [Google Scholar]
  50. Mencher G. T. 2000; Challenge ofepidemiological research in the developing world: overview. Audiology 39:178–183 [CrossRef]
    [Google Scholar]
  51. Moncada S., Palmer R. M., Higgs E. A. 1991; Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142
    [Google Scholar]
  52. Morizono T., Ikeda K. 1990).Effect; of Escherichia coli endotoxin on cochlear potentials followingits application to the chinchilla middle ear. Eur Arch Otorhinolaryngol 247:40–42
    [Google Scholar]
  53. Moss T. J., Nitsos I., Newnham J. P., Ikegami M., Jobe A. H. 2003; Chorioamnionitis induced by subchorionicendotoxin infusion in sheep. Am J Obstet Gynecol 189:1771–1776 [CrossRef]
    [Google Scholar]
  54. Mussi-Pinhata M. M., Yamamoto A. Y., Moura Brito R. M., deLima Isaac M., de Carvalho e Oliveira P. F., Boppana S., Britt W.J. 2009; Birth prevalence and natural history ofcongenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 49:522–528 [CrossRef]
    [Google Scholar]
  55. Mustafa M. M., Ramilo O., Olsen K. D., Franklin P. S., Hansen E. J., Beutler B., McCracken G. H. Jr 1989; Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest 84:1253–1259 [CrossRef]
    [Google Scholar]
  56. Nakai Y., Morimoto A., Chang K. C., Yamanaka M., Nishisato K. 1980; Inner ear damage induced by bacterial endotoxin. Arch Otorhinolaryngol 229:209–220 [CrossRef]
    [Google Scholar]
  57. Nance W. E., Lim B. G., Dodson K. M. 2006; Importance of congenital cytomegalovirus infections as acause for pre-lingual hearing loss. J Clin Virol 35:221–225 [CrossRef]
    [Google Scholar]
  58. Newnham J. P., Moss T. J., Kramer B. W., Nitsos I., Ikegami M., Jobe A. H. 2002; The fetal maturationaland inflammatory responses to different routes of endotoxin infusion in sheep. Am J Obstet Gynecol 186:1062–1068 [CrossRef]
    [Google Scholar]
  59. Nitsos I., Moss T. J., Cock M. L., Harding R., Newnham J. P. 2002; Fetal responses to intra-amniotic endotoxinin sheep. J Soc Gynecol Investig 9:80–85 [CrossRef]
    [Google Scholar]
  60. Paparella M. M., Brady D. R., Hoel R. 1970; Sensori-neural hearing loss in chronic otitis media andmastoiditis. Trans Am Acad Ophthalmol Otolaryngol 74:108–115
    [Google Scholar]
  61. Ramilo O., Mustafa M. M., Saez-Llorens X., Mertsola J., Ohkawara S., Yoshinaga M., Hansen E. J., McCracken G. H. Jr 1989; Role of interleukin 1-beta in meningeal inflammation. Pediatr Infect Dis J 8:909–910 [CrossRef]
    [Google Scholar]
  62. Romero R., Mazor M. 1988; Infectionand preterm labor. Clin Obstet Gynecol 31:553–584 [CrossRef]
    [Google Scholar]
  63. Sampson J. E., Theve R. P., Blatman R. N., Shipp T. D., Bianchi D. W., Ward B. E., Jack R. M. 1997; Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 176:77–81 [CrossRef]
    [Google Scholar]
  64. Schachern P. A., Paparella M. M., Hybertson R, Sano S., Duvall A. J. III 1992; Bacterial tympanogeniclabyrinthitis, meningitis, and sensorineural damage. Arch OtolaryngolHead Neck Surg 118:53–57
    [Google Scholar]
  65. Schmidt H. H., Walter U. 1994; NO at work. Cell 78:919–925 [CrossRef]
    [Google Scholar]
  66. Shi X., Dai C., Nuttall A. L. 2003; Altered expression of inducible nitric oxide synthase (iNOS)in the cochlea. Hear Res 177:43–52 [CrossRef]
    [Google Scholar]
  67. Spandow O., Anniko M., Moller A. R. 1988; The round window as access route for agents injurious to theinner ear. Am J Otolaryngol 9:327–335 [CrossRef]
    [Google Scholar]
  68. Spandow O., Anniko M., Hellstrom S. 1989; Inner ear disturbances following inoculation of endotoxin intothe middle ear. Acta Otolaryngol 107:90–96 [CrossRef]
    [Google Scholar]
  69. Spandow O., Hellstrom S., Anniko M. 1990; Structural changes in the round window membrane following exposureto Escherichia coli lipopolysaccharide and hydrocortisone. Laryngoscope 100:995–1000
    [Google Scholar]
  70. Suppiej A., Franzoi M., Vedovato S., Marucco A., Chiarelli S., Zanardo V. 2009; Neurodevelopmental outcomein preterm histological chorioamnionitis. Early Hum Dev 85:187–189 [CrossRef]
    [Google Scholar]
  71. Suzuki M., Yamasoba T., Kaga K. 1998; Development of the blood-labyrinth barrier in the rat. HearRes 116:107–112
    [Google Scholar]
  72. Takumida M., Anniko M. (1998).Lipopolysaccharide-induced expression of nitric oxide synthase II in the guineapig vestibular end organ. Eur Arch Otorhinolaryngol 255:184–188 [CrossRef]
    [Google Scholar]
  73. Takumida M., Anniko M. (2004a).Functional significance of nitric oxide in the inner ear. In Vivo 18:345–350
    [Google Scholar]
  74. Takumida M., Anniko M. (2004b).Localization of endotoxin in the inner ear following inoculation into themiddle ear. Acta Otolaryngol 124:772–777 [CrossRef]
    [Google Scholar]
  75. Takumida M., Anniko M., Popa R., Zhang D. M. 2000; Lipopolysaccharide-induced expression of induciblenitric oxide synthase in the guinea pig organ of Corti. Hear Res 140:91–98 [CrossRef]
    [Google Scholar]
  76. Tarlow M. J., Comis S. D., Osborne M. P. 1991; Endotoxin induced damage to the cochlea in guinea pigs. Arch Dis Child 66:181–184 [CrossRef]
    [Google Scholar]
  77. Trinidad A., Ramirez-Camacho R., Garcia-Berrocal J. R., Verdaguer J. M., Daza R. 2005; Labyrinthitis secondaryto experimental otitis media. Am J Otolaryngol 26:226–229 [CrossRef]
    [Google Scholar]
  78. Wang X., Rousset C. I., Hagberg H., Mallard C. 2006; Lipopolysaccharide-induced inflammation and perinatalbrain injury. Semin Fetal Neonatal Med 11:343–353 [CrossRef]
    [Google Scholar]
  79. Watanabe K., Naito N., Tanaka Y. 1995; Morphological changes in the inner ear induced by bacterialendotoxin. Med Electron Microsc 28:80–87 [CrossRef]
    [Google Scholar]
  80. Watanabe K., Hess A., Bloch W., Michel O. 2000a; Inhibition of inducible nitric oxide synthase lowers thecochlear damage by lipopolysaccharide in guinea pigs. Free RadicRes 32:363–370
    [Google Scholar]
  81. Watanabe K., Hess A., Zumeger C., Stennert E., Bloch W., Addicks K., Michel O. 2000b; Changes of thecompound action potential (CAP) and the expression of induciblenitric oxide synthase (iNOS/NOS II) in the cochlea under theinflammatory condition. Hear Res 145:149–155 [CrossRef]
    [Google Scholar]
  82. Watanabe K., Jinnouchi K., Pawankar R., Yagi T. 2001; Expression of myeloperoxidase and cochlear dysfunctionin the lipopolysaccharide-treated guinea pig. Eur Arch Otorhinolaryngol 258:164–167 [CrossRef]
    [Google Scholar]
  83. Watanabe K., Jinnouchi K., Yagi T. 2002; Immunoreactivity for myeloperoxidase (MPO) in thevestibule after the injection of bacterial lipopolysaccharide into the middleear. Auris Nasus Larynx 29:241–245 [CrossRef]
    [Google Scholar]
  84. Wild N. J., Sheppard S, Smithells R. W., Holzel H, Jones G. 1989; Onset and severity of hearing lossdue to congenital rubella infection. Arch Dis Child 64:1280–1283 [CrossRef]
    [Google Scholar]
  85. Yoon B. H., Romero R., Park J. S., Kim M., Oh S. Y., Kim C. J., Jun J. K. 2000; The relationship amonginflammatory lesions of the umbilical cord (funisitis), umbilicalcord plasma interleukin 6 concentration, amniotic fluid infection, and neonatalsepsis. Am J Obstet Gynecol 183:1124–1129 [CrossRef]
    [Google Scholar]
  86. Young T. E., Magnum O. B. 2007 Neofax: a Manual of Drugs used in Neonatal Care pp. 46–58 Montvale, NJ: Thomson;
    [Google Scholar]
  87. Zdanski C. J., Prazma J., Petrusz P., Grossman G., Raynor E., Smith T. L., Pillsbury H. C. 1994; Nitricoxide synthase is an active enzyme in the spiral ganglion cells of the ratcochlea. Hear Res 79:39–47 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.015792-0
Loading
/content/journal/jmm/10.1099/jmm.0.015792-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error